首页> 美国卫生研究院文献>Drugs in Context >Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

【2h】

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

机译：依维西汀作为重度抑郁症患者选择性5-羟色胺再摄取抑制剂抗抑郁药的辅助治疗的安全性和耐受性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective:The aim of this analysis was to assess the safety profile of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor (SSRI) antidepressants.

机译：目的：该分析的目的是评估依维西汀作为辅助治疗选择性5-羟色胺再摄取抑制剂（SSRI）抗抑郁药的安全性。

著录项

期刊名称 Drugs in Context
作者
James M Martinez; Margaret B Ferguson; Beth A Pangallo; Tina M Oakes; JonDavid Sparks; Mary Anne Dellva; Qi Zhang; Peng Liu; Mark Bangs; Jonna Ahl; Celine Goldberger;
展开▼
作者单位

展开▼
年(卷),期 2015(4),-1
年度 2015
页码 212279
总页数 10
原文格式 PDF
正文语种
中图分类药学;
关键词
norepinephrine reuptake inhibitor serotonin reuptake inhibitor second-generation antidepressive agent major depressive disorder adjunctive therapy drug safety drug tolerability;

机译：去甲肾上腺素再摄取抑制剂;5-羟色胺再摄取抑制剂;第二代抗抑郁药;重度抑郁症;辅助治疗;药物安全性;药物耐受性;

相似文献

外文文献
中文文献
专利

1. Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment [J] . Ball Susan G., Atkinson Sarah, Sparks JonDavid, Journal of clinical psychopharmacology . 2015,第3期

机译：长期，开放标签，依维西汀12至18 mg每天一次作为辅助治疗对部分抑郁症有部分反应的重度抑郁症患者的辅助治疗的安全性研究
2. Long-Term, Open-Label, Safety Study of Edivoxetine as Adjunctive Treatment for Adult Patients with Major Depressive Disorder Who Were Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment in Japan [J] . Emel Serap Monkul, Mark Bangs, Keita Asato, Open Journal of Psychiatry . 2015,第2期

机译：依维西汀作为辅助治疗对部分选择性5-羟色胺再摄取抑制剂治疗有部分反应的成年严重抑郁症成年患者的辅助治疗的长期，开放标签安全性研究
3. Efficacy Outcomes From 3 Clinical Trials of Edivoxetine as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment [J] . Beth A. Pangallo, E. Serap Monkul Nery, James M. Martinez, Primary care companion to the journal of clinical psychiatry . 2016,第5期

机译：依维西汀作为辅助治疗选择性5-羟色胺再摄取抑制剂治疗的部分主要抑郁症患者的辅助治疗的3项临床试验的疗效结果
4. Optoelectronic method for determinating the selective serotonin reuptake inhibitors antidepressants [C] . Maria Gabriela Neicu, Radu Macovei, Paul Schiopu, Advanced Topics in Optoelectronics, Microelectronics, and Nanotechnologies . 2019

机译：用于测定选择性血清素再摄取抑制剂抗抑郁药的光电方法
5. Serotonin Receptor Signaling Following Selective Serotonin Reuptake Inhibitor Treatment or: How I Learned to Stop Worrying and Love the Agonist. [D] . Van Dyke, Adam M. 2016

机译：选择性5-羟色胺再摄取抑制剂治疗后的5-羟色胺受体信号，或：我如何学会停止担心和热爱激动剂。
6. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy [O] . Jeffrey R. Strawn, Jeffrey A. Mills, Paul E. Croarkin -1

机译：在具有选择性5-羟色胺再摄取抑制剂抵抗的重度抑郁症青少年中切换选择性5-羟色胺再摄取抑制剂：平衡耐受性和功效
7. Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder [O] . James M Martinez, Margaret B Ferguson, Beth A Pangallo, 2015

机译：edivoxetine作为重度抑郁症患者抗抑郁药选择性5-羟色胺再摄取抑制剂的辅助治疗的安全性和耐受性

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

摘要

著录项

相似文献

相关主题

期刊订阅